LALL. Scott Hanson update. Originally looked at RO and biomarker data w LL. Near complete immune modulation was observed. Hanson incredibly impressed w LL. Jay and Cyrus were instrumental in deep dive of LL data to help drive the path for LL’s success. KOL’s and Statisticians were also drivers of this.

PrEP data is ongoing. 17 variations of LL are being tested.

LATCH trial has him excited about our future.